Trimed develops techniques for an immunologic treatment of cancer (cancer vaccines) based on the use of antigen-presenting IL-12 secreting dendritic cells.
Your email address will not be published. Required fields are marked *
Notify me of follow-up comments by email.
Notify me of new posts by email.